Results 21 to 30 of about 1,574,756 (175)

sj-docx-1-aan-10.1177_02184923231180990 - Supplemental material for Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis

, 2023
Supplemental material, sj-docx-1-aan-10.1177_02184923231180990 for Choice of intrapleural fibrinolytic agents in the treatment of adult complicated parapneumonic effusion and empyema: Network meta-analysis by Yujiro Yokoyama, Toshiki Kuno, Hisato Takagi ...
Yujiro Yokoyama (9919476), William Burfeind (16229320), Toshiki Kuno (450365), Hisato Takagi (6179822)   +3 more
core   +1 more source

Non-sterile Submerged Fermentation of Fibrinolytic Enzyme by Marine Bacillus subtilis Harboring Antibacterial Activity With Starvation Strategy

Frontiers in Microbiology, 2019
Microbial fibrinolytic enzyme is a promising candidate for thrombolytic therapy. Non-sterile production of fibrinolytic enzyme by marine Bacillus subtilis D21-8 under submerged fermentation was realized at a mild temperature of 34°C, using a unique ...
Shihan Pan, Guiguang Chen, Rui Wu, Xiaoyan Cao, Zhiqun Liang   +4 more
doaj   +1 more source

Fibrinolytic Enzyme from Green Microalgae: A New Potential Drug for Thrombolytic Therapy?

Phycology, 2023
Thrombosis is characterized by the pathological formation of fibrin clots within a blood vessel, leading to the obstruction of blood flow. Fibrinolytic enzymes from microorganisms have been shown to be more efficient and safer in dissolving clots.
Yanara Alessandra Santana Moura, Ariadne Tennyle Vieira De Souza, Páblo Eugênio Da Costa e Silva, Marllyn Marques Da Silva, Ana Lúcia Figueiredo Porto, Raquel Pedrosa Bezerra   +5 more
doaj   +1 more source

Food Origin Fibrinolytic Enzyme With Multiple Actions

Hayati Journal of Biosciences, 2018
Many health related problems such as cardiovascular diseases are associated with the formation of excessive clot in the blood (thrombus). Approaches in cardiovascular disease treatment are preventing the formation or removing the thrombus.
Laurentia Stephani, Raymond Rubianto Tjandrawinata, Diana Nur Afifah, Yanti Lim, Wangsa Tirta Ismaya, Maggy Thenawidjaja Suhartono   +5 more
doaj   +1 more source

Exploring Agaricomycetes from the Paranaense rainforest (Misiones, Argentina) as an unconventional source of fibrinolytic enzymes

, 2022
Fungal fibrinolytic enzymes, secreted by some Agaricomycetes, are recognized as important thrombolytic agents due to their ability to rapidly dissolve thromboembolic clots. The present work evaluated fibrinolytic and proteolytic secretion abilities of 35
Fonseca, Maria Isabel, Acosta, Gabriela Alejandra, Fariña, Julia Ines, Zapata, Pedro Dario, Pedro Darío Zapata, Gabriela Alejandra Acosta, Julia Inés Fariña, María Isabel Fonseca   +7 more
core   +1 more source

Admission Tpe interval predicts reperfusion success in STEMI patients treated with fibrinolytic agents

Türk Kardiyoloji Derneği Arşivi, 2020
Objective: Myocardial infarction is a leading cause of morbidity and mortality. Fibrinolytic administration is still a life-saving choice in ST-segment elevated myocardial infarction (STEMI), but the rate of successful reperfusion can be inconsistent ...
Ali Çoner, Sinan Akıncı, Mehmet Hüsamettin Akküçük, Cihan Altın, Haldun Müderrisoğlu   +4 more
doaj   +1 more source

Choice of Intrapleural Fibrinolytic Agents in the Treatment of Adult Complicated Parapneumonic Effusion and Empyema: Network Meta-Analysis

, 2023
Background: The appropriate use of intrapleural fibrinolytic agents in patients with complicated parapneumonic effusion and empyema remains unclear, especially regarding the choice of fibrinolytic agents.
Takagi, Hisato, Yokoyama, Yujiro, Burfeind, William, Kuno, Toshiki   +3 more
core   +1 more source

Biosimilar tenecteplase versus alteplase in acute ischemic stroke: A real world study

Annals of Indian Academy of Neurology, 2023
Background and Purpose: There is an unmet need for a more effective thrombolytic agent in acute ischemic stroke (AIS) management. Various studies and meta-analysis suggest tenecteplase (TNK) as non-inferior over alteplase (rTPA).
Ayush Mohan, Snigdha Komakula, Suhas Murali, Pooja Anand, Dyuti Shah, V Y Vishnu, Awadh Kishor Pandit, Ayush Agarwal, Deepti Vibha, Mamta Bhushan Singh, M V Padma Srivastava, Rohit Bhatia   +11 more
doaj   +1 more source

The study of the pharmacological activity of thick extract from the leaves of Corylus avellana on the model of peripheral vascular thrombophlebitis in rabbit ear

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2017
Creation of accessible domestic drug for the treatment and prevention of thrombotic venous damage, which would be able to adjust maximum range of disorders with minimal side effects, is actual direction of the pharmacology.
L. M. Maloshtan, A. S. Kalenichenko
doaj   +1 more source

In vitro characterization of jellyfish venom fibrin(ogen)olytic enzymes from Nemopilema nomurai

Journal of Venomous Animals and Toxins including Tropical Diseases, 2017
Background Because jellyfish are capable of provoking envenomation in humans, they are considered hazardous organisms. Although the effects of their toxins are a matter of concern, information on the venom components, biological activity and pathological
Seong Kyeong Bae, Hyunkyoung Lee, Yunwi Heo, Min Jung Pyo, Indu Choudhary, Chang Hoon Han, Won Duk Yoon, Changkeun Kang, Euikyung Kim   +8 more
doaj   +1 more source